All Capital Management articles
-
News
Guy Carpenter appoints Dimitrijevic to lead APAC capital advisory
The reinsurance broker’s new regional head of capital advisory was previously led Swiss Re’s P&C business management for Asia Pacific.
-
News
Swiss Re secures $700m in second stop-loss deal with JP Morgan
Transaction offers the reinsurer “cost-efficient capital that can be deployed in the current attractive market”
-
News
Hesitant capital remains sidelined despite rating improvements - AM best
High levels of nat cat losses, coupled with rising inflation and geopolitical concerns, is denting appetite for property cat
-
News
Why redundant reserves are a $1 billion problem - Pro
Market has over $1 billion in unused loss fund reserves, despite claims being paid in full
-
News
1/1 ‘down to the wire’ with possible reputational consequences
Areas of most constraint were peak-zone US property cat and coverage for war and SRCC, finds Gallagher Re’s 1st View
-
News
Ian will have ‘devastating impact’ on full-year underwriting results
Continued rise in interest rates will further pressure total investment returns and reported book values - Aon
-
News
Reinsurance market reaches ‘a tipping point’ - Howden
Risks are escalating as the world lurches from one crisis to another, bringing about a fundamental shift in supply and demand, warns broker
-
News
AM Best puts Italian insurers on negative outlook
Economic uncertainty, declining profitability and elevated risk profiles are causes for concern
-
News
AM Best lowers Argo Re’s BCAR score
Material adverse reserve development in 2021 raises new concerns
-
News
Swiss Re targets ROE of 14% for 2024
The Group has completed its turnaround of Corporate Solutions and improved P&C margins - CEO Mumenthaler
-
News
Insurance industry must find ‘right’ capital management strategy to navigate losses
The insurance industry must find the “right” capital management strategy to navigate losses. One driver for this is social inflation, however the change in legal environment, different mindsets in juries, third party claims and medical advancements have all made claims increase.